Yale Cancer Experts to Present This Week at Top International Oncology Conference

Later this week, Yale Cancer Center (YCC) experts will present new research at the 2025 European Society for Medical Oncology (ESMO) Congress in Madrid, Spain. ESMO, from Oct. 17-21 this year, is one of the leading global oncology conferences, bringing together scientists, clinicians, and healthcare professionals to share the latest advancements in cancer research and treatment.

This year’s ESMO Congress is themed “Integrating Science into Oncology for a Better Patient Journey,” emphasizing the importance of innovation and collaboration in improving cancer care. YCC researchers will deliver oral presentations, participate in panel discussions, and lead educational sessions covering a wide range of topics, including targeted therapies, biomarkers for resistance to immunotherapy, innovative combination therapies for advanced colorectal cancer, and advancements in patient supportive care.

YCC Presentations at ESMO 2025

October 17

• Proffered Paper Session: Supportive and Palliative Care Speaker: Maryam Lustberg, MD
• Satellite Symposium: Emerging Evidence Supporting c-Met Protein-Directed Strategies in GI Cancer Presenter: Michael Cecchini, MD
• Satellite Symposium: Panel Discussion and Q&A Speaker: Dr. Michael Cecchini

October 18

• Educational Session: Quantitative Spatial Analysis Presenter: Kurt Schalper, MD, PhD

October 19

• Mini Oral Session: Telisotuzumab Adizutecan (ABBV-400; Temab-A) in Combination with Bevacizumab (Bev) vs Standard of Care (SOC) in Patients with 3L+ Colorectal Cancer (CRC) – Dose Expansion Results of a Phase 1 Study Presenter: Dr. Michael Cecchini

October 20

• Mini Oral Session: Breast Cancer, Metastatic Chair: Ian Krop, MD, PhD

• Satellite Symposium: Current Strategies in Clinical Practice to Support and Advocate for Patients Experiencing CIPN (Chemotherapy-Induced Peripheral Neuropathy) Presenter: Dr. Maryam Lustberg

YCC’s presence at ESMO 2025 reflects its commitment to advancing cancer research and improving patient care through innovation and collaboration.

For media interviews with Yale Cancer Center experts, please contact Michael Masciadrelli at michael.masciadrelli@yale.edu.

About Yale Cancer Center: Yale Cancer Center combines a tradition of pioneering cancer treatment with a commitment to compassionate, patient-focused care. A National Cancer Institute (NCI)-designated comprehensive cancer center since 1974, YCC is one of only 57 such centers in the United States and the only one in Connecticut. YCC members include leading scientists and clinicians from Yale School of Medicine and Smilow Cancer Hospital, working together to deliver cutting-edge research and the highest quality care to patients.